Max Rosett - 29 Jul 2025 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
Chief Financial Officer
Signature
/s/ Sandra Stoneman, Attorney-in-Fact
Issuer symbol
IMNM
Transactions as of
29 Jul 2025
Net transactions value
$0
Form type
4
Filing time
31 Jul 2025, 18:59:16 UTC
Previous filing
20 Sep 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rosett Max Chief Financial Officer C/O IMMUNOME, INC., 18702 N. CREEK PARKWAY, SUITE 100, BOTHELL /s/ Sandra Stoneman, Attorney-in-Fact 31 Jul 2025 0001994071

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMNM Employee Stock Option (right to buy) Award $0 +207,000 $0.000000 207,000 29 Jul 2025 Common Stock 207,000 $10.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the options vest on July 29, 2026, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter.